The most challenging year ever is how listed drug maker AFT Pharmaceuticals is describing the last 12 months, a period of time that straddles profound Covid disruption of export markets.
However, the drug maker did manage to grow revenue by 7% in the financial year to March 31, 2020, to $113.1
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
